PHOENIX MOLECULAR DESIGNS

phoenix-molecular-designs-logo

Phoenix Molecular Designs is developing precise cancer therapeutics with a platform technology focused on developing first-in-class kinase inhibitors designed to uniquely target p90 ribosomal S6 kinase (RSK). Their world-renowned leadership team boasts over 100 years of oncology experience from notable affiliations such as Genentech, Pfizer and Eli Lily. The company completed a Phase 1 first-in-human clinical trial with lead asset, PMD-026, as of Oct 2020, treating women with metastatic breast cancer. A Phase 1b mono-therapy trial is now open in triple negative breast cancer (TNBC) in 9 leading medical centers across the United States.

#People #Financial #Website #More

PHOENIX MOLECULAR DESIGNS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2012-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.phoenixmd.ca

Total Employee:
11+

Status:
Active

Contact:
+1 604 674 1796

Email Addresses:
[email protected]

Total Funding:
12.35 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business



Current Advisors List

not_available_image

Nicholas Sharp Board Member @ Phoenix Molecular Designs
Board_member

alan-ashworth_image

Alan Ashworth Scientific Advisor @ Phoenix Molecular Designs
Advisor

julia-levy_image

Julia Levy Board Member @ Phoenix Molecular Designs
Board_member

not_available_image

Mike Varney Scientific Advisor @ Phoenix Molecular Designs
Advisor

not_available_image

Robert Levak Board Member @ Phoenix Molecular Designs
Board_member

lana-janes_image

Lana Janes Board Member @ Phoenix Molecular Designs
Board_member

not_available_image

Janet Grove Board Member @ Phoenix Molecular Designs
Board_member

sanjeev-thohan_image

Sanjeev Thohan Scientific Advisor @ Phoenix Molecular Designs
Advisor

Current Employees Featured

not_available_image

Aarthi Jayanthan
Aarthi Jayanthan Chief Operating Officer @ Phoenix Molecular Designs
Chief Operating Officer

not_available_image

Will Clodfelter
Will Clodfelter Chief Business Officer @ Phoenix Molecular Designs
Chief Business Officer

not_available_image

Gerrit Los
Gerrit Los Chief Scientific Officer @ Phoenix Molecular Designs
Chief Scientific Officer

not_available_image

Dorr Andrew
Dorr Andrew Chief Medical Officer @ Phoenix Molecular Designs
Chief Medical Officer

not_available_image

John Van Drie
John Van Drie Chief Technology Officer @ Phoenix Molecular Designs
Chief Technology Officer

sandra-dunn_image

Sandra Dunn
Sandra Dunn CEO and Founder @ Phoenix Molecular Designs
CEO and Founder

lesley-esford_image

Lesley Esford
Lesley Esford VP of Strategic Alliances @ Phoenix Molecular Designs
VP of Strategic Alliances

mike-liggett_image

Mike Liggett
Mike Liggett Chief Financial officer @ Phoenix Molecular Designs
Chief Financial officer

Founder


sandra-dunn_image

Sandra Dunn

Investors List

the-51-ventures_image

The 51 Ventures

The 51 Ventures investment in Seed Round - Phoenix Molecular Designs

pallasite-ventures_image

Pallasite Ventures

Pallasite Ventures investment in Seed Round - Phoenix Molecular Designs

world-changing-ventures_image

World Changing Ventures

World Changing Ventures investment in Seed Round - Phoenix Molecular Designs

pallasite-ventures_image

Pallasite Ventures

Pallasite Ventures investment in Seed Round - Phoenix Molecular Designs

Official Site Inspections

http://www.phoenixmd.ca Semrush global rank: 7.66 M Semrush visits lastest month: 447

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Phoenix Molecular Designs" on Search Engine